Literature DB >> 10482820

Mast cell-T cell interactions.

Y A Mekori1, D D Metcalfe.   

Abstract

In addition to being a major effector cell in the elicitation of allergic inflammation, mast cells have been found to be activated in various T cell-mediated inflammatory processes and to reside in close physical proximity to T cells. Such observations and the wide spectrum of mediators produced and secreted by mast cells have led investigators to propose a functional relationship between these 2 cell populations. Indeed, mast cell activation has been reported to induce T-cell migration either directly by the release of chemotactic factors, such as lymphotactin or IL-16, or indirectly by the induction of adhesion molecule expression on endothelial cells. Mast cells are also able to present antigens to T cells, resulting in their activation in either an MHC class I- or class II-restricted and costimulatory molecule-dependent fashion. Adhesion molecule-dependent intercellular contact or MHC class II cognate interactions between T cells and mast cells result in the release of both granule-associated mediators and cytokines from the latter. Also, T cell-derived mediators, such as beta-chemokines, directly induce mast cell degranulation. On the other hand, mast cell-derived cytokines, such as IL-4, have been found to polarize T cells to preferentially differentiate into the T(H2) subset. Thus T cell-mast cell interactions are bidirectional, fulfilling regulatory and/or modulatory roles affecting various aspects of the immune response.

Entities:  

Mesh:

Year:  1999        PMID: 10482820     DOI: 10.1016/s0091-6749(99)70316-7

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  41 in total

Review 1.  Mast cells and inflammation.

Authors:  Theoharis C Theoharides; Konstantinos-Dionysios Alysandratos; Asimenia Angelidou; Danae-Anastasia Delivanis; Nikolaos Sismanopoulos; Bodi Zhang; Shahrzad Asadi; Magdalini Vasiadi; Zuyi Weng; Alexandra Miniati; Dimitrios Kalogeromitros
Journal:  Biochim Biophys Acta       Date:  2010-12-23

2.  Thymic stromal lymphopoietin-induced interleukin-17A is involved in the development of IgE-mediated atopic dermatitis-like skin lesions in mice.

Authors:  Nobuaki Mizutani; Chutha Sae-Wong; Sureeporn Kangsanant; Takeshi Nabe; Shin Yoshino
Journal:  Immunology       Date:  2015-09-24       Impact factor: 7.397

3.  Mast cells enhance T cell activation: Importance of mast cell-derived TNF.

Authors:  Susumu Nakae; Hajime Suto; Maki Kakurai; Jonathon D Sedgwick; Mindy Tsai; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

Review 4.  Immunomodulatory mast cells: negative, as well as positive, regulators of immunity.

Authors:  Stephen J Galli; Michele Grimbaldeston; Mindy Tsai
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

5.  Characterization of ERK activation in human mast cells stimulated by contact with T cells.

Authors:  Adam Mor; Irit Shefler; Pazit Salamon; Yoel Kloog; Yoseph A Mekori
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

6.  Cognate interactions between mast cells and helper T lymphocytes.

Authors:  Salvatore Valitutti; Eric Espinosa
Journal:  Self Nonself       Date:  2010-03-17

Review 7.  Evolving immune circuits are generated by flexible, motile, and sequential immunological synapses.

Authors:  Audrey Gérard; Peter Beemiller; Rachel S Friedman; Jordan Jacobelli; Matthew F Krummel
Journal:  Immunol Rev       Date:  2013-01       Impact factor: 12.988

8.  Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.

Authors:  Alon Y Hershko; Ryo Suzuki; Nicolas Charles; Damiana Alvarez-Errico; Jennifer L Sargent; Arian Laurence; Juan Rivera
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

Review 9.  Autoimmune urticaria.

Authors:  Malcolm Greaves
Journal:  Clin Rev Allergy Immunol       Date:  2002-10       Impact factor: 8.667

10.  Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice.

Authors:  Maciej Chichlowski; Greg S Westwood; Soman N Abraham; Laura P Hale
Journal:  PLoS One       Date:  2010-08-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.